YWYuebing Wang

Yuebing Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuebing Wang has a total of 142 co-authors. Here are the top co-authors by number of shared publications:

  • Hongmei Cao

    Key Laboratory of Radiopharmacokinetics for Innovative Drugs Chinese Academy of Medical Sciences Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300192 China

    7 shared publications
  • Deling Kong

    5 shared publications
  • Deling Kong

    Key Laboratory of Bioactive Materials for the Ministry of Education College of Life Sciences State Key Laboratory of Medicinal Chemical Biology Nankai University Tianjin 300071 China

    5 shared publications
  • Lanxing Wang

    School of Medicine, Institute of Transplant Medicine, Tianjin First Central Hospital, Nankai University, 300071, China; The Key Laboratory of Bioactive Materials, Ministry of Education, The College of Life Science, Nankai University, Tianjin 300071, China

    5 shared publications
  • Yanwen Zhang

    5 shared publications
  • Zongjin Li

    Nankai University School of Medicine Tianjin China

    5 shared publications

Latest Publications

  • Open Access

    A topologically engineered hydrogel platform targeting IL11 promotes renal repair after partial nephrectomy

    by Zeming Yu, Xianhao Dong, Feiyi Li, Yanwen Zhang, Shuxin Dai, Ning Cao, Xiaopeng Jia, Jie Zhao, Bing Wang, Wenxiu Chang, et al.

  • Open Access

    Discovery and validation of a urinary extracellular vesicle protein signature for the diagnosis of renal allograft fibrosis

    by Wenxuan Zhao, Yang Xu, Yuewen Wang, Shihao Jin, Wenhui Wang, Zeming Yu, Yanwen Zhang, Yuxin Zhang, Deling Kong, Bing Wang, et al.

    Interstitial fibrosis is the best indicator of irreversible or ongoing renal injury after kidney transplantation and faces considerable diagnostic challenges. Owing to the direct connection between urine and kidney, small urinary extracellular vesicles (suEVs) are promising candidates for developing non‐invasive and highly sensitive diagnostic biomarkers for allograft fibrosis. Herein, we established an optimized method for separating suEVs from renal transplant recipients with high yield and purity. Through unbiased proteomic and in‐depth bioinformatic analyses, we delineated an extensive protein landscape of suEVs and identified sorting nexin 3 (SNX3), vacuolar protein sorting‐associated protein 4B (VPS4B) and smoothened (SMO) proteins as potential biomarkers for accurate and consistent diagnosis of fibrosis. Extensive validation across three independent cohorts demonstrated their excellent diagnostic performance in both transplant recipients and chronic kidney disease patients, achieving an outstanding AUC value of 0.9909 and accuracy of 90.6%, respectively. Moreover, this model demonstrated a prognostic value in a 3‐month follow‐up assessment of renal allograft recipients. Mechanically, we indicated that SNX3 promotes fibroblast activation through the regulation of Wnt secretion. Our study is the first to report the suEV protein biomarkers for the diagnosis of allograft fibrosis, offering a non‐invasive alternative to renal biopsy and enabling improved risk stratification for transplant patients, which aids in better management of transplant recipients to improve long‐term allograft survival.

  • Mesenchymal Stem Cell Spheroids Induced by Supramolecular Nanofibers for Diabetic Wound Healing

    by Yanwen Zhang, Sifan Ai, Zeming Yu, Lanxing Wang, Hui Tao, Bing Wang, Deling Kong, Zhimou Yang, Yuebing Wang

    Diabetic wounds, which are a serious complication of diabetes, are a threat to most diabetic patients and there is a lack of satisfactory therapeutic strategies. Mesenchymal stem cell (MSC) spheroids are under intensive investigation and have emerged as a particularly promising clinical therapy to induce wound healing; however, clinical applications of MSC spheroids have lagged because of the difficulties related to proper preparation, in situ instruction and insufficient efficacy. Herein, a novel Biotin‐DFYIGSR supramolecular hydrogel is designed for three‐dimensional (3D) culture of MSCs, which enables monodispersed MSCs to form cell spheroids with high efficacy and is fairly suitable for quick spheroid harvest. MSC spheroids are demonstrated with enhanced paracrine function, which exhibited increased cell survival and promoted three overlapping stages of wound healing through the integrin α2β1 subunits. These spheroids not only accelerated the wound transition from the inflammatory phase to proliferation phase by inhibiting neutrophils and inducing M2 macrophage transition, but also promoted cell proliferation and neovascularization at wound sites to motivate skin regeneration. Ultimately, MSC spheroids achieved re‐epithelialization and collagen deposition for desirable wound closure. MSC spheroids induced by Biotin‐DFYIGSR are a facile solution for the safe and efficient treatment of diabetic wounds, with great potential for clinical application.


  • Engineered Cytokine‐Primed Extracellular Vesicles with High PD‐L1 Expression Ameliorate Type 1 Diabetes

    by Lanxing Wang, Chunxiao Qi, Hongmei Cao, Yanwen Zhang, Xing Liu, Lina Qiu, Hang Wang, Lijuan Xu, Zhenzhou Wu, Jianfeng Liu, et al.

    Type 1 diabetes (T1D), which is a chronic autoimmune disease, results from the destruction of insulin‐producing β cells targeted by autoreactive T cells. The recent discovery that mesenchymal stem cell‐derived extracellular vesicles (MSC‐EVs) function as therapeutic tools for autoimmune conditions has attracted substantial attention. However, the in vivo distribution and therapeutic effects of MSC‐EVs potentiated by pro‐inflammatory cytokines in the context of T1D have yet to be established. Here, it is reported that hexyl 5‐aminolevulinate hydrochloride (HAL)‐loaded engineered cytokine‐primed MSC‐EVs (H@TI‐EVs) with high expression of immune checkpoint molecule programmed death‐legend 1 (PD‐L1) exert excellent inflammatory targeting and immunosuppressive effects for T1D imaging and therapy. The accumulated H@TI‐EVs in injured pancreas not only enabled the fluorescence imaging and tracking of TI‐EVs through the intermediate product protoporphyrin (PpIX) generated by HAL, but also promoted the proliferative and anti‐apoptotic effects of islet β cells. Further analysis revealed that H@TI‐EVs exhibited an impressive ability to reduce CD4+ T cell density and activation through the PD‐L1/PD‐1 axis, and induced M1‐to‐M2 macrophage transition to reshape the immune microenvironment, exhibiting high therapeutic efficiency in mice with T1D. This work identifies a novel strategy for the imaging and treatment of T1D with great potential for clinical application.


  • Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood–brain barrier disruption in murine ischemic stroke models

    by Lina Qiu, Ying Cai, Yanqin Geng, Xiuhua Yao, Lanxing Wang, Hongmei Cao, Xuebin Zhang, Qiaoli Wu, Deling Kong, Dan Ding, et al.


  • Macrophage-Membrane-Camouflaged Nonviral Gene Vectors for the Treatment of Multidrug-Resistant Bacterial Sepsis

    by Hongmei Cao, Yang Gao, Haixue Jia, Liping Zhang, Jinjian Liu, Ganen Mu, Han Gui, Yuebing Wang, Cuihong Yang, Jianfeng Liu

    Sepsis is a life-threatening disease caused by systemic bacterial infections, with high morbidity and mortality worldwide. As the standard treatment for sepsis, antibiotic therapy faces the challenge of impaired macrophages and drug-resistant bacteria. In this study, we developed a membrane-camouflaged metal-organic framework (MOF) system for plasmid DNA (pDNA) delivery to combat sepsis. The antimicrobial gene LL37 was efficiently encapsulated in the pH-sensitive MOF, and the nanoparticles were decorated with macrophage membranes in a compatible manner. Macrophage membrane coating allows targeted delivery of LL37 to macrophages and creates macrophage factories for the continuous generation of antimicrobial peptides. Compared to naked nanoparticles, primary bone marrow mesenchymal macrophage membrane-modified nanoparticles greatly improved the survival rate of immunodeficient septic mice through the synergistic effect of efficient gene therapy and inflammatory cytokine sequestration. This study demonstrates an effective membrane biomimetic strategy for efficiently delivering pDNA, offering an excellent option for overcoming sepsis.


  • Biosynthetic Dendritic Cell-Exocytosed Aggregation-Induced Emission Nanoparticles for Synergistic Photodynamic Immunotherapy

    by Hongmei Cao, Heqi Gao, Lanxing Wang, Yuanqiu Cheng, Xiaoli Wu, Xiaohong Shen, Hang Wang, Zhen Wang, Panpan Zhan, Jianfeng Liu, et al.

    Dendritic cell (DC)-derived small extracellular vesicles (DEVs) are recognized as a highly promising alternative to DC vaccines; however, the clinical testing of DEV-based immunotherapy has shown limited therapeutic efficacy. Herein, we develop a straightforward strategy in which DCs serve as a cell reactor to exocytose high-efficient DEV-mimicking aggregation-induced emission (AIE) nanoparticles (DEV-AIE NPs) at a scaled-up yield for synergistic photodynamic immunotherapy. Exocytosed DEV-AIE NPs inherit not only the immune-modulation proteins from parental DCs, enabling T cell activation, but also the loaded AIE-photosensitizer MBPN-TCyP, inducing superior immunogenic cell death (ICD) by selectively accumulating in the mitochondria of tumor cells. Eventually, DEV-AIE synergistic photodynamic immunotherapy elicits dramatic immune responses and efficient eradication of primary tumors, distant tumors, and tumor metastases. In addition, cancer stem cells (CSCs) in 4T1 and CT26 solid tumors were significantly inhibited by the immune functional DEV-AIE NPs. Our work presents a facile method for the cellular generation of EV-biomimetic NPs and demonstrates that the integration of DEVs and AIE photosensitizers is a powerful direction for the production of clinical anticancer nanovaccines.


  • Open Access

    Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy

    by Yuan-Qiu Cheng, Yu-Xin Yue, Hong-Mei Cao, Wen-Chao Geng, Lan-Xing Wang, Xin-Yue Hu, Hua-Bin Li, Qiang Bian, Xiang-Lei Kong, Jian-Feng Liu, et al.

    Background: Hypoxia is a major contributor to global kidney diseases. Targeting hypoxia is a promising therapeutic option against both acute kidney injury and chronic kidney disease; however, an effective strategy that can achieve simultaneous targeted kidney hypoxia imaging and therapy has yet to be established. Herein, we fabricated a unique nano-sized hypoxia-sensitive coassembly (Pc/C5A@EVs) via molecular recognition and self-assembly, which is composed of the macrocyclic amphiphile C5A, the commercial dye sulfonated aluminum phthalocyanine (Pc) and mesenchymal stem cell-excreted extracellular vesicles (MSC-EVs). Results: In murine models of unilateral or bilateral ischemia/reperfusion injury, MSC-EVs protected the Pc/C5A complex from immune metabolism, prolonged the circulation time of the complex, and specifically led Pc/C5A to hypoxic kidneys via surface integrin receptor α4β1 and αLβ2, where Pc/C5A released the near-infrared fluorescence of Pc and achieved enhanced hypoxia-sensitive imaging. Meanwhile, the coassembly significantly recovered kidney function by attenuating cell apoptosis, inhibiting the progression of renal fibrosis and reducing tubulointerstitial inflammation. Mechanistically, the Pc/C5A coassembly induced M1-to-M2 macrophage transition by inhibiting the HIF-1α expression in hypoxic renal tubular epithelial cells (TECs) and downstream NF-κB signaling pathway to exert their regenerative effects. Conclusion: This synergetic nanoscale coassembly with great translational potential provides a novel strategy for precise kidney hypoxia diagnosis and efficient kidney injury treatment. Furthermore, our strategy of coassembling exogenous macrocyclic receptors with endogenous cell-derived membranous structures may offer a functional platform to address multiple clinical needs. Graphical


  • Top Cited Papers

    In Vivo Tracking of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improving Mitochondrial Function in Renal Ischemia–Reperfusion Injury

    by Hongmei Cao, Yuanqiu Cheng, Heqi Gao, Jie Zhuang, Weiguang Zhang, Qiang Bian, Fang Wang, Yuan Du, Zongjin Li, Deling Kong, et al.

    Extracellular vesicles (EVs) released by mesenchymal stem cells (MSCs) have exhibited regenerative capability in animal models of ischemia-reperfusion (I/R) acute kidney injury (AKI) and are considered as potential alternatives to direct MSC therapy. However, real-time in vivo imaging of MSC-EVs in renal I/R injury has yet to be established. Renal intracellular targets of MSC-EVs responsible for their regenerative effects also remain elusive. Here, we report that we real-time observed MSC-EVs specially accumulated in the injured kidney and taken up by renal proximal tubular epithelia cells (TECs) via DPA-SCP with aggregation-induced emission (AIE) characteristics. DPA-SCP precisely tracked the fate of MSC-EVs in a renal I/R injury mouse model for 72 hours and exhibited superior spatiotemporal resolution and tracking ability to popular commercially available EV tracker PKH26. Further analysis revealed that the accumulated MSC-EVs stimulated mitochondrial antioxidant defense and ATP production via activating the Keap1-Nrf2 signaling pathway, which protected TECs against oxidative insult by reducing mitochondrial fragmentation, normalizing mitochondrial membrane potential and increasing mitochondrial DNA copy number. Increased microRNA-200a-3p expression in renal TECs induced by MSC-EVs was identified as a regulatory mechanism contributing to the protective actions on mitochondria as well as stimulating the renal signal transduction pathways. In conclusion, MSC-EVs accumulated in the renal tubules during renal I/R injury and promoted the recovery of kidney function via activating Keap1-Nrf2 signaling pathway and enhancing mitochondrial function of TECs. DPA-SCP with AIE characteristics allows non-invasive and precise in vivo visualization of MSC-EVs in kidney repair.